Literature DB >> 2159360

The effects of N-methyl-D-aspartate receptor blockade with MK-801 upon the relationship between cerebral blood flow and glucose utilisation.

D G Nehls1, C K Park, A G MacCormack, J McCulloch.   

Abstract

The local cerebral circulatory and metabolic effects of MK-801, a selective non-competitive N-methyl-D-aspartate receptor antagonist have been examined in conscious rats with quantitative autoradiographic techniques using [14C]iodoantipyrine and [14C]2-deoxyglucose as tracers. Local cerebral blood flow (CBF) and local cerebral glucose utilisation (GU) were measured in 41 discrete neuroanatomical loci using identical criteria for region of interest localisation. Animals received either saline or MK-801 (0.5 mg/kg in saline) intravenously 10 min prior to the start of GU determination, or 15 min before the CBF measurement. MK-801 effects an immediate transient, elevation in mean arterial pressure (elevated by 30% from baseline) which returned rapidly to preinjection levels and a sustained moderate hypercapnia (arterial carbon dioxide tension increased by 16%) which persisted throughout the measurement periods. Statistically significant changes in GU were observed in 13 brain region structures after MK-801 administration. Glucose utilisation was significantly and markedly elevated with MK-801 in some limbic structures (particularly the hippocampus, posterior cingulate and entorhinal cortices), the inferior colliculus and most of the neocortex displayed moderate reductions in GU after MK-801 treatment. In the majority of brain regions (28 or the 41 studied), MK-801 minimally altered GU. There were widespread alterations in local CBF with MK-801 although in the majority of brain regions (24 of the 41 studied) there was no statistically significant alteration in CBF with MK-801. With one exception (the anterior thalamic nucleus), CBF was increased with MK-801 in all regions in which glucose use was elevated with the drug.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159360     DOI: 10.1016/0006-8993(90)90172-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

Review 1.  Autoradiographic assessment of the effects of N-methyl-D-aspartate (NMDA) receptor antagonists in vivo.

Authors:  J McCulloch; L L Iversen
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

Review 2.  Excitatory amino acid receptors in normal and abnormal vestibular function.

Authors:  P F Smith; C de Waele; P P Vidal; C L Darlington
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

3.  At least three neurotransmitter systems mediate a stress-induced increase in c-fos mRNA in different rat brain areas.

Authors:  E Bozas; N Tritos; H Phillipidis; F Stylianopoulou
Journal:  Cell Mol Neurobiol       Date:  1997-04       Impact factor: 5.046

4.  Differential effects of NMDA and AMPA glutamate receptors on functional magnetic resonance imaging signals and evoked neuronal activity during forepaw stimulation of the rat.

Authors:  Willy Gsell; Michael Burke; Dirk Wiedermann; Gilles Bonvento; Afonso C Silva; François Dauphin; Christian Bührle; Mathias Hoehn; Wolfram Schwindt
Journal:  J Neurosci       Date:  2006-08-16       Impact factor: 6.167

5.  Effects of excitatory amino acids on cerebral oxygen consumption and blood flow in rat.

Authors:  X Lu; A K Sinha; H R Weiss
Journal:  Neurochem Res       Date:  1997-06       Impact factor: 3.996

6.  Persisting changes in brain glucose uptake following neurotoxic doses of phencyclidine which mirror the acute effects of the drug.

Authors:  G D Ellison; A S Keys
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

7.  Competitive as well as uncompetitive N-methyl-D-aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism.

Authors:  R J Hargreaves; M Rigby; D Smith; R G Hill; L L Iversen
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

8.  Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology.

Authors:  R J Hargreaves; M Rigby; D Smith; R G Hill
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

9.  Down-regulation of AMPA glutamate receptors reduces cerebrocortical metabolic response to stimulation.

Authors:  Arabinda K Sinha; Romeu Azevedo; Oak Z Chi; Harvey R Weiss
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

10.  Blockade by polyamine NMDA antagonists related to ifenprodil of NMDA-induced synthesis of cyclic GMP, increases in calcium and cytotoxicity in cultured neurones.

Authors:  P M Beart; A Schousboe; A Frandsen
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.